005500 — Samjin Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapSuper Stock

Market Cap
KR₩216bn
Enterprise Value
KR₩334bn
Revenue
KR₩308bn

Annual balance sheet for Samjin Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	24,489	11,711	4,663	4,006	3,705
Net Total Accounts Receivable
Net Total Receivables	51,429	57,684	59,883	61,455	62,673
Total Inventory
Prepaid Expenses
Total Current Assets	146,860	139,872	134,268	146,180	159,105
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	102,526	168,901	198,068	191,640	192,505
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	269,033	332,496	406,557	419,901	425,166
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	33,935	49,514	81,652	144,550	159,130
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	55,577	98,328	131,213	154,536	163,511
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	213,456	234,168	275,344	265,365	261,655
Total Liabilities & Shareholders' Equity	269,033	332,496	406,557	419,901	425,166
Total Common Shares Outstanding